A key advisory panel to the Centers for Disease Control and Prevention (CDC) voted Thursday to endorse the administration of Pfizer’s COVID-19 booster shots to those 65 and older, nursing home residents, and people who are 50 to 64 with underlying medical conditions.
The advisory panel’s endorsement clears the way for the CDC to give the final approval for millions of people to receive booster shots. It could happen as soon as Thursday night.
The panel’s backing comes a day after the Food and Drug Administration (FDA) amended its emergency use authorization for Pfizer’s booster shots, allowing people 65 years and older to get the third dose.
The FDA says that adults at high risk for severe COVID-19 may also be eligible for the booster shot. Adults who work in situations that expose them to severe COVID-19 risk are also eligible.
According to FDA, boosters should not be administered more than 6 months after the completion of a first vaccination series that includes two shots.
The Pfizer vaccine currently has the booster. The FDA needs to review the data from Moderna, Johnson & Johnson before authorizing a booster shot.